Addressing diabetes racial and ethnic disparities: lessons learned from quality improvement collaboratives.

Diabetes Management
Abigail E WilkesMonica E Peek

Abstract

A review of national data confirms that while the quality of healthcare in the USA is slowly improving, disparities in diabetes prevalence, processes of care and outcomes for racial/ethnic minorities are not. Many quality measures can be addressed through system level interventions, referred to as quality improvement (QI), and QI collaboratives have been found to effectively improve processes of care for chronic conditions, including diabetes. However, the impact of QI collaboratives on the reduction of health disparities has been mixed. Lessons learned from previous QI collaboratives including the complexity of impacting clinical outcomes, the need for expert support for skills outside of QI methodology, limiting impact of poor data, and the need to develop disparities quality measures, can be used to inform future QI collaborative approaches to reduce diabetes racial/ethnic minority health disparities.

References

Jan 8, 1999·The Milbank Quarterly·D Blumenthal, C M Kilo
Mar 8, 2000·American Journal of Public Health·M H ChinW L McNabb
Mar 20, 2002·Health Affairs·John S McAlearney
Aug 3, 2002·Journal of the National Medical Association·Alan Nelson
Sep 10, 2002·Medical Care·Howard S GordonCarol M Ashton
Feb 25, 2003·JAMA : the Journal of the American Medical Association·Ashwini R Sehgal
Mar 29, 2003·Diabetes Care·Christopher D MillerImad M El-Kebbi
Dec 25, 2003·Diabetes Care·Marshall H ChinUNKNOWN Midwest cluster health disparities collaborative
Apr 7, 2004·Archives of General Psychiatry·Kenneth WellsLisa Rubenstein
May 26, 2004·Archives of Internal Medicine·Richard W GrantDaniel E Singer
Aug 6, 2004·The New England Journal of Medicine·Peter B BachJ Lee Hargraves
Mar 11, 2005·Health Affairs·Nicole LurieRisa Lavizzo-Mourey
Mar 22, 2005·Medical Care·Mary Catherine BeachLisa A Cooper
Aug 19, 2005·The New England Journal of Medicine·Amal N TrivediJohn Z Ayanian
Mar 29, 2006·Archives of Internal Medicine·Thomas D SequistJohn Z Ayanian
Mar 30, 2006·Joint Commission Journal on Quality and Patient Safety·Marsha GoldJessica Mittler
Mar 3, 2007·The New England Journal of Medicine·Bruce E LandonEdward Guadagnoli
Oct 19, 2007·Medical Care Research and Review : MCRR·Monica E PeekElbert S Huang
Jan 10, 2008·Diabetes Care·UNKNOWN American Diabetes Association
May 22, 2008·Joint Commission Journal on Quality and Patient Safety·Nicole LurieDonna Zimmerman
Jun 26, 2008·BMJ : British Medical Journal·Loes M T SchoutenRichard P T M Grol
Sep 11, 2008·Health Affairs·Robert A BerensonAimee F Williams
Feb 2, 2010·American Journal of Preventive Medicine·Katie Brooks BielloJeannette R Ickovics
Jun 25, 2010·The New England Journal of Medicine·Mark R ChassinRobert M Wachter
Nov 30, 2010·Implementation Science : IS·Loes Mt SchoutenRichard Ptm Grol

❮ Previous
Next ❯

Citations

Jan 28, 2014·Current Diabetes Reports·Monica E PeekMarshall H Chin
Dec 24, 2013·Journal of Immigrant and Minority Health·Ruwei HuChien-Chou Chen
Apr 6, 2013·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Rachel VossRebekah Gardner
Dec 20, 2014·Health Services Research·Jennifer M JosephMary L Frederick
Feb 9, 2018·Primary Health Care Research & Development·Neil S CalmanCasey Crump
Dec 4, 2019·Annals of the New York Academy of Sciences·Pamela L ThorntonCarol M Mangione
Jun 12, 2020·BMC Public Health·Sivan Spitzer-ShohatMary Cj Rudolf
Sep 29, 2018·Journal of Community Health·Ivan MarquezCasey Crump

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Medical Care Research and Review : MCRR
Monica E PeekElbert S Huang
The Journal of Ambulatory Care Management
Peter ShinJessica Sharac
Quality & Safety in Health Care
Marshall H Chin, Abigail E Wilkes
© 2021 Meta ULC. All rights reserved